Verity Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VERITY, and when can generic versions of VERITY drugs launch?
VERITY has four approved drugs.
There are fourteen US patents protecting VERITY drugs.
There are seventy-two patent family members on VERITY drugs in thirty-five countries.
Drugs and US Patents for Verity
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Verity | TLANDO | testosterone undecanoate | CAPSULE;ORAL | 208088-001 | Mar 28, 2022 | RX | Yes | Yes | 11,304,960 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Verity | TLANDO | testosterone undecanoate | CAPSULE;ORAL | 208088-001 | Mar 28, 2022 | RX | Yes | Yes | 11,311,555 | ⤷ Subscribe | ⤷ Subscribe | ||||
Verity | TLANDO | testosterone undecanoate | CAPSULE;ORAL | 208088-001 | Mar 28, 2022 | RX | Yes | Yes | 11,364,249 | ⤷ Subscribe | ⤷ Subscribe | ||||
Verity | TLANDO | testosterone undecanoate | CAPSULE;ORAL | 208088-001 | Mar 28, 2022 | RX | Yes | Yes | 9,943,527 | ⤷ Subscribe | ⤷ Subscribe | ||||
Verity | TLANDO | testosterone undecanoate | CAPSULE;ORAL | 208088-001 | Mar 28, 2022 | RX | Yes | Yes | 8,778,922 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Verity | TLANDO | testosterone undecanoate | CAPSULE;ORAL | 208088-001 | Mar 28, 2022 | RX | Yes | Yes | 9,949,985 | ⤷ Subscribe | ⤷ Subscribe | ||||
Verity | TLANDO | testosterone undecanoate | CAPSULE;ORAL | 208088-001 | Mar 28, 2022 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Verity
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Verity | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 020715-001 | Jun 15, 2000 | 5,134,122 | ⤷ Subscribe |
Verity | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 021288-001 | Jun 29, 2001 | 5,776,885 | ⤷ Subscribe |
Verity | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 021288-001 | Jun 29, 2001 | 5,192,741 | ⤷ Subscribe |
Verity | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 021288-001 | Jun 29, 2001 | 5,225,205 | ⤷ Subscribe |
Verity | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 020715-001 | Jun 15, 2000 | 5,192,741 | ⤷ Subscribe |
Verity | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 020715-001 | Jun 15, 2000 | 5,225,205 | ⤷ Subscribe |
Verity | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 020715-001 | Jun 15, 2000 | 5,776,885 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Verity Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
China | 102271665 | ⤷ Subscribe |
Malaysia | 150450 | ⤷ Subscribe |
Serbia | 58248 | ⤷ Subscribe |
Slovenia | 2164467 | ⤷ Subscribe |
South Korea | 101631475 | ⤷ Subscribe |
Spain | 2694401 | ⤷ Subscribe |
Uruguay | 35445 | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.